Skip to content

Caregiver Outlook: An Intervention to Improve Caregiving in Serious Illness

Caregiver Outlook: An Intervention to Improve Caregiving in Serious Illness

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01672294
Enrollment
286
Registered
2012-08-24
Start date
2013-06-30
Completion date
2016-04-30
Last updated
2017-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Heart Failure, Pulmonary Disease

Keywords

caregiver, end of life, self-disclosure

Brief summary

Informal caregivers provide a majority of care for patients during serious illness. Lack of preparation and completion may leave caregivers less capable of caring for a loved one or making crucial decisions influencing care. This study will examine whether a preparation and completion intervention reduces caregiver anxiety, depression, anticipatory grief, and burden and improves patient quality of life and health care use.

Detailed description

The investigators propose a randomized control trial to evaluate an intervention of preparation and completion with Veterans and their caregivers during serious illness. Specific aims are to 1) Evaluate the impact of the caregiver Outlook intervention on caregiver anxiety, depression, anticipatory grief, completion, and burden; 2) Evaluate the impact of the home versus in hospital, emergency department, or nursing facility; 3) Evaluate the impact of the intervention session's qualitative content, examining variation associated with selected demographic variables, quality of family communication, and stage of illness on change. Caregivers in the first group (Treatment, or Preparation and life completion) will meet with a facilitator three times for a period of forty-five minutes each. In the first session, subjects will be asked to discuss issues related to relationship life review. In session two, participants will be asked to speak in more depth about issues such as regret and forgiveness. In the final session, subjects will focus on legacy and celebration. Caregivers in the second group (attention control or relaxation meditation) will meet with a facilitator three times for a period of forty-five minutes each and be asked to listen to a non-guided relaxation compact disk (CD) or participate in a guided relaxation exercise. Participants in both groups will receive pre and post-test measures administered by a blinded interviewer. Outcome measures will be measures by the Functional Assessment of Cancer Therapy - General (FACT-G), Quality of life scale, FACIT-sp sub-scale, Anticipatory Grief Scale, Caregiver Reaction Assessment, the Qual-E completion and preparation sub-scales, and patient days at home.

Interventions

OTHERPreparation and life completion

Caregiver subjects will discuss life review, issues of forgiveness and heritage and legacy.

OTHERAttention Control

Caregiver subjects will listen to a non-guided relaxation CD with facilitator.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Patients with advanced cancer/Congestive heart failure/COPD/End stage renal disease who have a primary caregiver. Caregivers of Durham VAMC patients with advanced disease.

Exclusion criteria

* No caregiver present. * Caregiver with Cognitive impairment/inability to speak on phone/non-English speaking

Design outcomes

Primary

MeasureTime frameDescription
Caregiver AnxietyMeasured at baseline, 5 weeks, and 8 weeksProfile of Moods States (POMS) anxiety sub-scale The anxiety sub-scale from the modified Brief Profile of Mood States (POMS),7110 a six-item measure of psychological distress. Individual items used a 5 point Likert scale (0-4). The sub-scale minimum score was 0 and maximum was 24 (more anxious ).

Secondary

MeasureTime frameDescription
DepressionMeasured at baseline, 5 weeks, and 8 weeksCenters for Epidemiologic Study of Depression short form (CES-D) is a 10-item measure of depression. Items are rated on a 4 point Likert scale (0-3) with total scores ranging from 0 to 30. Higher scores indicate greater depressive symptoms
Patient Days of VA Hospital UseIn the 6 months after randomizationThe number of days that a patient used either the VA emergency department (ED) or was an inpatient at a VA hospital in the 6 months following randomization. Inclusion of non-VA utilization was made unpractical due to the long delay in filing for non VA reimbursement (up to 2 years). The original variable was Day AT home, defined to be 180 days minus the days in ED or inpatient hospital. This was changed to days of use due to distribution/modeling considerations.
Caregiver BurdenMeasured at baseline, 5 weeks, and 8 weeksCaregiver Reaction Assessment (CRA). The Caregiver Reaction Assessment is a 24-item multidimensional instrument designed to measure a caregiver's reactions to caregiving for family members with a variety of chronic illnesses. The esteem subscale has 7 items with a 5 level Likert scale: 1=Strongly Disagree to 5=Strongly Agree. The score is the average of the 7 items ranging from a low score of 1 associated with negative reactions and high score of 5 with positive reactions.
SpiritualityMeasured at baseline, 5 weeks, and 8 weeksFunctional Assessment of Chronic Illness Therapy - Spiritual Well-Being (FACIT-SP) subscale. The 12-item measure assess spiritual well-being: faith, meaning, and purpose. Individual items use a 5 point likert scale (0-4). The scale minimum score is 0 (negative well being) and maximum is 48 (positive well being).
Prolonged Grief - Number of Participants With Anticipatory GriefMeasured at baseline, 5 weeks, and 8 weeksThe Prolong Grief Disorder scale is a clinically-based diagnosis determination scale modified for this study. The components/requirements that were dropped were a) diagnosis should not be made until at least 6 months since death, and b) the disturbance is not better accounted for major depressive disorder, generalized anxiety disorder or post traumatic stress disorder. The outcome was a dichotomized variable with 1 indicating symptoms of prolonged grief are present and 0 indicating insufficient symptoms.
Caregiver PreparationMeasured at baseline, 5 weeks, and 8 weeksQuality of life at the End of Life (Family Edition) is a 17-item measure of quality of life at the end of life assessing five domains: life completion, relationship with health care providers, preparation for death, physical symptoms and affective social support. The 5-item preparation subscale uses a 5 point (0-4) Likert scale. The subscale ranges from 0 (poor) to 4 (better outcome).
Caregiver CompletionMeasured at baseline, 5 weeks, and 8 weeksQuality of life at the End of Life (Family Edition) is a 17-item measure of quality of life at the end of life assessing five domains: life completion, relationship with health care providers, preparation for death, physical symptoms and affective social support. The 3-item Life Completion subscale uses a 5 point (0-4) Likert scale. The subscale ranges from 0 (poor) to 4 (better outcome).

Countries

United States

Participant flow

Recruitment details

The study conducted recruitment from June 2013 to October 2015. Potential patients were identified by data pulls and then medical record review as well as obtaining approval to approach from providers. Patients were approached both at select outpatient clinics at the Durham VAMC as well as being sent invitation letters with subsequent phone calls.

Pre-assignment details

Participant pairs (seriously-ill veteran and primary informal caregiver) were consented and then each completed a baseline interview before the dyad was randomized. Enrolled participants may be excluded if either of the pair refused to consent or did not complete a baseline.

Participants by arm

ArmCount
Caregiver Outlook - Caregiver
Intervention: Three facilitator-led preparation and life completion sessions with caregiver. Topics included life review, issues of forgiveness and heritage and legacy.
71
Caregiver Outlook - Patient
Intervention: Three facilitator-led preparation and life completion sessions with caregiver. Topics included life review, issues of forgiveness and heritage and legacy.
71
Relaxation Meditation - Caregiver
Attention Control: Three facilitator led sessions of caregivers listening to a non-guided relaxation CD.
72
Relaxation Meditation - Patient
Attention Control: Three facilitator led sessions of caregivers listening to a non-guided relaxation CD..
72
Total286

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyExcluded by study1100
Overall StudyLost to Follow-up11679
Overall StudyWithdrawal by Subject4444

Baseline characteristics

CharacteristicTotalCaregiver Outlook - CaregiverCaregiver Outlook - PatientRelaxation Meditation - CaregiverRelaxation Meditation - Patient
Age, Continuous63.3 years
STANDARD_DEVIATION 10.59
60.8 years
STANDARD_DEVIATION 11.32
66.8 years
STANDARD_DEVIATION 7.85
60.1 years
STANDARD_DEVIATION 12.05
65.4 years
STANDARD_DEVIATION 9.21
Dyad Relationship
Adult Child
12 Participants6 Participants2 Participants3 Participants1 Participants
Dyad Relationship
Other
40 Participants8 Participants8 Participants12 Participants12 Participants
Dyad Relationship
Parent
12 Participants2 Participants6 Participants1 Participants3 Participants
Dyad Relationship
Sibling
12 Participants3 Participants3 Participants3 Participants3 Participants
Dyad Relationship
Spouse
210 Participants52 Participants52 Participants53 Participants53 Participants
Education
College Degree
29 Participants12 Participants6 Participants5 Participants6 Participants
Education
Graduate Work or Degree
24 Participants3 Participants7 Participants8 Participants6 Participants
Education
HS or less
126 Participants34 Participants33 Participants28 Participants31 Participants
Education
Some College
107 Participants22 Participants25 Participants31 Participants29 Participants
Employment
Disabled
77 Participants7 Participants32 Participants10 Participants28 Participants
Employment
Other
1 Participants0 Participants0 Participants1 Participants0 Participants
Employment
Retired/Not Working
163 Participants43 Participants38 Participants42 Participants40 Participants
Employment
Working Full or Part Time
45 Participants21 Participants1 Participants19 Participants4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants3 Participants2 Participants2 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
277 Participants68 Participants69 Participants68 Participants72 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants0 Participants0 Participants2 Participants0 Participants
Finances
Difficulty paying bills
35 Participants10 Participants13 Participants6 Participants6 Participants
Finances
enough to pay bills and special things
87 Participants22 Participants22 Participants21 Participants22 Participants
Finances
Enough to pay bills, little extras
101 Participants26 Participants22 Participants23 Participants30 Participants
Finances
Missing
1 Participants0 Participants0 Participants0 Participants1 Participants
Finances
Money to pay bills, cut back on things
62 Participants13 Participants14 Participants22 Participants13 Participants
Number of Hours patient requires assistance2.3 hours
STANDARD_DEVIATION 1.26
2.4 hours
STANDARD_DEVIATION 1.24
2.3 hours
STANDARD_DEVIATION 1.34
2.3 hours
STANDARD_DEVIATION 1.2
2.1 hours
STANDARD_DEVIATION 1.25
Primary Diagnosis of Veteran
Cancer
95 Participants43 Participants52 Participants
Primary Diagnosis of Veteran
Chronic obstructive pulmonary disease
17 Participants12 Participants5 Participants
Primary Diagnosis of Veteran
Congestive Heart Failure
12 Participants6 Participants6 Participants
Primary Diagnosis of Veteran
End Stage Renal Disease
12 Participants6 Participants6 Participants
Primary Diagnosis of Veteran
Multiple Qualifying Disease
7 Participants4 Participants3 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
122 Participants31 Participants29 Participants30 Participants32 Participants
Race (NIH/OMB)
More than one race
17 Participants4 Participants4 Participants7 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants0 Participants0 Participants2 Participants0 Participants
Race (NIH/OMB)
White
145 Participants36 Participants38 Participants33 Participants38 Participants
Region of Enrollment
United States
286 participants71 participants71 participants72 participants72 participants
Self-rated Quality of Health
Excellent
1 Participants0 Participants0 Participants1 Participants0 Participants
Self-rated Quality of Health
Fair
46 Participants9 Participants14 Participants9 Participants14 Participants
Self-rated Quality of Health
Good
49 Participants16 Participants11 Participants14 Participants8 Participants
Self-rated Quality of Health
Missing
141 Participants36 Participants36 Participants35 Participants34 Participants
Self-rated Quality of Health
Poor
21 Participants0 Participants9 Participants0 Participants12 Participants
Self-rated Quality of Health
Very Good
28 Participants10 Participants1 Participants13 Participants4 Participants
Sex: Female, Male
Female
141 Participants67 Participants4 Participants67 Participants3 Participants
Sex: Female, Male
Male
145 Participants4 Participants67 Participants5 Participants69 Participants
Years of caregiving given or received4.2 years
STANDARD_DEVIATION 5.04
4.6 years
STANDARD_DEVIATION 5.6
5.2 years
STANDARD_DEVIATION 5.95
3.7 years
STANDARD_DEVIATION 4.06
3.4 years
STANDARD_DEVIATION 4.2

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
4 / 717 / 714 / 7211 / 72
serious
Total, serious adverse events
0 / 7113 / 710 / 7211 / 72

Outcome results

Primary

Caregiver Anxiety

Profile of Moods States (POMS) anxiety sub-scale The anxiety sub-scale from the modified Brief Profile of Mood States (POMS),7110 a six-item measure of psychological distress. Individual items used a 5 point Likert scale (0-4). The sub-scale minimum score was 0 and maximum was 24 (more anxious ).

Time frame: Measured at baseline, 5 weeks, and 8 weeks

Population: Comparing Caregiver anxiety levels between the Outlook and the Relaxation meditation arm. Differences in numbers analyzed versus group totals due to missing data.

ArmMeasureGroupValue (MEAN)Dispersion
Caregiver Outlook - CaregiverCaregiver AnxietyBaseline6.9 units on a scaleStandard Deviation 5.3
Caregiver Outlook - CaregiverCaregiver Anxiety5 week follow up5.9 units on a scaleStandard Deviation 5.2
Caregiver Outlook - CaregiverCaregiver Anxiety8 week follow up5.8 units on a scaleStandard Deviation 5.7
Relaxation Meditation - CaregiverCaregiver AnxietyBaseline7.3 units on a scaleStandard Deviation 4.6
Relaxation Meditation - CaregiverCaregiver Anxiety5 week follow up5.4 units on a scaleStandard Deviation 4.9
Relaxation Meditation - CaregiverCaregiver Anxiety8 week follow up6.4 units on a scaleStandard Deviation 5.1
Comparison: Note- missing the first follow up at 5 weeks did not prohibit an individual from participating at the second follow up at 8 weeks.p-value: <0.51195% CI: [-1.0776, 2.1528]Mixed Models Analysis
Comparison: Note- missing the first follow up at 5 weeks did not prohibit an individual from participating at the second follow up at 8 weeks.p-value: 0.634895% CI: [-1.3505, 2.2055]Mixed Models Analysis
Secondary

Caregiver Burden

Caregiver Reaction Assessment (CRA). The Caregiver Reaction Assessment is a 24-item multidimensional instrument designed to measure a caregiver's reactions to caregiving for family members with a variety of chronic illnesses. The esteem subscale has 7 items with a 5 level Likert scale: 1=Strongly Disagree to 5=Strongly Agree. The score is the average of the 7 items ranging from a low score of 1 associated with negative reactions and high score of 5 with positive reactions.

Time frame: Measured at baseline, 5 weeks, and 8 weeks

Population: Comparing Caregiver reaction assessment scores between the Outlook Intervention and the Relaxation Meditation arm.Differences in numbers analyzed versus group totals due to missing data.

ArmMeasureGroupValue (MEAN)Dispersion
Caregiver Outlook - CaregiverCaregiver BurdenBaseline4.2 units on a scaleStandard Deviation 0.6
Caregiver Outlook - CaregiverCaregiver Burden5 week4.2 units on a scaleStandard Deviation 0.6
Caregiver Outlook - CaregiverCaregiver Burden8 week4.2 units on a scaleStandard Deviation 0.6
Relaxation Meditation - CaregiverCaregiver BurdenBaseline4.2 units on a scaleStandard Deviation 0.6
Relaxation Meditation - CaregiverCaregiver Burden5 week4.2 units on a scaleStandard Deviation 0.6
Relaxation Meditation - CaregiverCaregiver Burden8 week4.1 units on a scaleStandard Deviation 0.6
Comparison: Between Outlook Intervention caregivers and active control caregivers at 5 weeks.~Note- missing the first follow up at 5 weeks did not prohibit an individual from participating at the second follow up at 8 weeks.p-value: 0.768795% CI: [-0.1372, 0.1017]Mixed Models Analysis
Comparison: Between Outlook Intervention caregivers and active control caregivers at 8 weeks Note- missing the first follow up at 5 weeks did not prohibit an individual from participating at the second follow up at 8 weeks.p-value: 0.986395% CI: [-0.1003, 0.09861]Mixed Models Analysis
Secondary

Caregiver Completion

Quality of life at the End of Life (Family Edition) is a 17-item measure of quality of life at the end of life assessing five domains: life completion, relationship with health care providers, preparation for death, physical symptoms and affective social support. The 3-item Life Completion subscale uses a 5 point (0-4) Likert scale. The subscale ranges from 0 (poor) to 4 (better outcome).

Time frame: Measured at baseline, 5 weeks, and 8 weeks

Population: Comparing life completion scores between the Outlook Intervention and the Relaxation meditation arm, caregivers only. Differences in numbers analyzed versus group totals due to missing data.

ArmMeasureGroupValue (MEAN)Dispersion
Caregiver Outlook - CaregiverCaregiver CompletionBaseline2.7 units on a scaleStandard Deviation 0.8
Caregiver Outlook - CaregiverCaregiver Completion5 Week2.5 units on a scaleStandard Deviation 0.9
Caregiver Outlook - CaregiverCaregiver Completion8 Week2.5 units on a scaleStandard Deviation 1
Relaxation Meditation - CaregiverCaregiver CompletionBaseline2.8 units on a scaleStandard Deviation 0.8
Relaxation Meditation - CaregiverCaregiver Completion5 Week2.6 units on a scaleStandard Deviation 0.9
Relaxation Meditation - CaregiverCaregiver Completion8 Week2.7 units on a scaleStandard Deviation 0.8
Comparison: At 5 weeks - Completion subscalep-value: 0.922195% CI: [-0.2475, 0.2241]Mixed Models Analysis
Comparison: Comparison at 8 week time point Note- Missing first follow up at 5 weeks did not prohibit an individual from participating at the second follow up at 8 week.p-value: 0.324995% CI: [-0.3466, 0.1158]Mixed Models Analysis
Secondary

Caregiver Preparation

Quality of life at the End of Life (Family Edition) is a 17-item measure of quality of life at the end of life assessing five domains: life completion, relationship with health care providers, preparation for death, physical symptoms and affective social support. The 5-item preparation subscale uses a 5 point (0-4) Likert scale. The subscale ranges from 0 (poor) to 4 (better outcome).

Time frame: Measured at baseline, 5 weeks, and 8 weeks

Population: Comparing preparation scores between the Outlook Intervention and the Relaxation meditation arm, caregivers only. Two scale items were inadvertently left out initially. Items were added back in when omission was noted. However, the large number of missing makes analysis inappropriate.

ArmMeasureGroupValue (MEAN)Dispersion
Caregiver Outlook - CaregiverCaregiver PreparationBaseline2.7 units on a scaleStandard Deviation 0.7
Caregiver Outlook - CaregiverCaregiver Preparation5 Week2.4 units on a scaleStandard Deviation 0.8
Caregiver Outlook - CaregiverCaregiver Preparation8 Week2.6 units on a scaleStandard Deviation 0.8
Relaxation Meditation - CaregiverCaregiver PreparationBaseline2.4 units on a scaleStandard Deviation 0.8
Relaxation Meditation - CaregiverCaregiver Preparation5 Week2.7 units on a scaleStandard Deviation 0.7
Relaxation Meditation - CaregiverCaregiver Preparation8 Week2.6 units on a scaleStandard Deviation 0.8
Secondary

Depression

Centers for Epidemiologic Study of Depression short form (CES-D) is a 10-item measure of depression. Items are rated on a 4 point Likert scale (0-3) with total scores ranging from 0 to 30. Higher scores indicate greater depressive symptoms

Time frame: Measured at baseline, 5 weeks, and 8 weeks

Population: Primary and secondary results are comparing caregiver scores in the two arms, not patient arms.

ArmMeasureGroupValue (MEAN)Dispersion
Caregiver Outlook - CaregiverDepressionBaseline8.2 units on a scaleStandard Deviation 6.6
Caregiver Outlook - CaregiverDepression5 weeks8.7 units on a scaleStandard Deviation 6.8
Caregiver Outlook - CaregiverDepression7 weeks8.3 units on a scaleStandard Deviation 6.2
Relaxation Meditation - CaregiverDepressionBaseline8.8 units on a scaleStandard Deviation 5.5
Relaxation Meditation - CaregiverDepression5 weeks8.0 units on a scaleStandard Deviation 6.4
Relaxation Meditation - CaregiverDepression7 weeks9.0 units on a scaleStandard Deviation 6.4
Comparison: Between Outlook Intervention caregivers and active control caregivers at 5 weeks Note- missing the first follow up at 5 weeks did not prohibit an individual from participating at the second follow up at 8 weeks.p-value: <0.333295% CI: [-0.9726, 2.8443]Mixed Models Analysis
Comparison: Between Outlook Intervention caregivers and active control caregivers at 8 weeks Note - Missing the first follow up at 5 weeks did not prohibit an individual from participating at the second follow up at 8 weeksp-value: 0.384295% CI: [-0.8783, 2.2642]Mixed Models Analysis
Secondary

Patient Days of VA Hospital Use

The number of days that a patient used either the VA emergency department (ED) or was an inpatient at a VA hospital in the 6 months following randomization. Inclusion of non-VA utilization was made unpractical due to the long delay in filing for non VA reimbursement (up to 2 years). The original variable was Day AT home, defined to be 180 days minus the days in ED or inpatient hospital. This was changed to days of use due to distribution/modeling considerations.

Time frame: In the 6 months after randomization

ArmMeasureValue (MEAN)Dispersion
Caregiver Outlook - CaregiverPatient Days of VA Hospital Use4.4 Days in VA hospital or ERStandard Deviation 11.8
Relaxation Meditation - CaregiverPatient Days of VA Hospital Use4.4 Days in VA hospital or ERStandard Deviation 9.6
p-value: 0.874895% CI: [-0.6784, 0.797]Standard negative binomial with offset
Secondary

Prolonged Grief - Number of Participants With Anticipatory Grief

The Prolong Grief Disorder scale is a clinically-based diagnosis determination scale modified for this study. The components/requirements that were dropped were a) diagnosis should not be made until at least 6 months since death, and b) the disturbance is not better accounted for major depressive disorder, generalized anxiety disorder or post traumatic stress disorder. The outcome was a dichotomized variable with 1 indicating symptoms of prolonged grief are present and 0 indicating insufficient symptoms.

Time frame: Measured at baseline, 5 weeks, and 8 weeks

Population: Number of participants indicating prolonged grief across the Outlook Intervention and the Relaxation meditation arm, caregivers only. Only six percent of the sample qualified as having prolonged grief, at baseline. Therefore there was not sufficient data for statistical modeling.

ArmMeasureGroupValue (NUMBER)
Caregiver Outlook - CaregiverProlonged Grief - Number of Participants With Anticipatory GriefBaseline6 participants
Caregiver Outlook - CaregiverProlonged Grief - Number of Participants With Anticipatory Grief5 week2 participants
Caregiver Outlook - CaregiverProlonged Grief - Number of Participants With Anticipatory Grief8 week2 participants
Relaxation Meditation - CaregiverProlonged Grief - Number of Participants With Anticipatory GriefBaseline2 participants
Relaxation Meditation - CaregiverProlonged Grief - Number of Participants With Anticipatory Grief5 week3 participants
Relaxation Meditation - CaregiverProlonged Grief - Number of Participants With Anticipatory Grief8 week2 participants
Secondary

Spirituality

Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being (FACIT-SP) subscale. The 12-item measure assess spiritual well-being: faith, meaning, and purpose. Individual items use a 5 point likert scale (0-4). The scale minimum score is 0 (negative well being) and maximum is 48 (positive well being).

Time frame: Measured at baseline, 5 weeks, and 8 weeks

Population: Comparing spiritual well being levels between the Outlook and the Relaxation meditation arms, Caregivers only.

ArmMeasureGroupValue (MEAN)Dispersion
Caregiver Outlook - CaregiverSpiritualityBaseline35.4 units on a scaleStandard Deviation 9
Caregiver Outlook - CaregiverSpirituality5 week36.1 units on a scaleStandard Deviation 8
Caregiver Outlook - CaregiverSpirituality8 week37.3 units on a scaleStandard Deviation 8.3
Relaxation Meditation - CaregiverSpiritualityBaseline37.3 units on a scaleStandard Deviation 7.2
Relaxation Meditation - CaregiverSpirituality5 week37.3 units on a scaleStandard Deviation 7
Relaxation Meditation - CaregiverSpirituality8 week36.6 units on a scaleStandard Deviation 7.6
Comparison: Comparison at 5 weeks Note- missing the first follow up at 5 weeks did not prohibit an individual from participating at the second follow up at 8 weeks.p-value: 0.522595% CI: [-1.4278, 2.795]Mixed Models Analysis
Comparison: Comparison at 8 weeks. Note-missing the first follow up at 5 weeks did not prohibit an individual from participating at the second follow up at 8 weeks.p-value: 0.197295% CI: [-0.6728, 3.2257]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026